ADL-CDF: A Deep Learning Framework for COVID-19 Detection from CT Scans Towards an Automated Clinical Decision Support System

Integrated ensemble CNN and explainable AI for COVID-19 diagnosis from CT scan and X-ray images

In light of the ongoing battle against COVID-19, while the pandemic may eventually subside, sporadic cases may still emerge, underscoring the need for accurate detection from radiological images. However, the limited explainability of current deep learning models restricts clinician acceptance. To address this issue, our research integrates multiple CNN models with explainable AI techniques, ensuring model interpretability before ensemble construction. Our approach enhances both accuracy and interpretability by evaluating advanced CNN models on the largest publicly available X-ray dataset, COVIDx CXR-3, which includes 29,986 images, and the CT scan dataset for SARS-CoV-2 from Kaggle, which includes a total of 2,482 images. We also employed additional public datasets for cross-dataset evaluation, ensuring a thorough assessment of model performance across various imaging conditions. By leveraging methods including LIME, SHAP, Grad-CAM, and Grad-CAM++, we provide transparent insights into model decisions. Our ensemble model, which includes DenseNet169, ResNet50, and VGG16, demonstrates strong performance. For the X-ray image dataset, sensitivity, specificity, accuracy, F1-score, and AUC are recorded at 99.00%, 99.00%, 99.00%, 0.99, and 0.99, respectively. For the CT image dataset, these metrics are 96.18%, 96.18%, 96.18%, 0.9618, and 0.96, respectively. Our methodology bridges the gap between precision and interpretability in clinical settings by combining model diversity with explainability, promising enhanced disease diagnosis and greater clinician acceptance.

Clinical decision support systems (CDSS) in assistance to COVID-19 diagnosis: A scoping review on types and evaluation methods

Background and Aims

Due to the COVID-19 pandemic, a precise and reliable diagnosis of this disease is critical. The use of clinical decision support systems (CDSS) can help facilitate the diagnosis of COVID-19. This scoping review aimed to investigate the role of CDSS in diagnosing COVID-19.

Methods

We searched four databases (Web of Science, PubMed, Scopus, and Embase) using three groups of keywords related to CDSS, COVID-19, and diagnosis. To collect data from studies, we utilized a data extraction form that consisted of eight fields. Three researchers selected relevant articles and extracted data using a data collection form. To resolve any disagreements, we consulted with a fourth researcher.

Results

A search of the databases retrieved 2199 articles, of which 68 were included in this review after removing duplicates and irrelevant articles. The studies used nonknowledge-based CDSS (n = 52) and knowledge-based CDSS (n = 16). Convolutional Neural Networks (CNN) (n = 33) and Support Vector Machine (SVM) (n = 8) were employed to design the CDSS in most of the studies. Accuracy (n = 43) and sensitivity (n = 35) were the most common metrics for evaluating CDSS.

Conclusion

CDSS for COVID-19 diagnosis have been developed mainly through machine learning (ML) methods. The greater use of these techniques can be due to their availability of public data sets about chest imaging. Although these studies indicate high accuracy for CDSS based on ML, their novelty and data set biases raise questions about replacing these systems as clinician assistants in decision-making. Further studies are needed to improve and compare the robustness and reliability of nonknowledge-based and knowledge-based CDSS in COVID-19 diagnosis.

A Systematic Review on Deep Structured Learning for COVID-19 Screening Using Chest CT from 2020 to 2022

The emergence of the COVID-19 pandemic in Wuhan in 2019 led to the discovery of a novel coronavirus. The World Health Organization (WHO) designated it as a global pandemic on 11 March 2020 due to its rapid and widespread transmission. Its impact has had profound implications, particularly in the realm of public health. Extensive scientific endeavors have been directed towards devising effective treatment strategies and vaccines. Within the healthcare and medical imaging domain, the application of artificial intelligence (AI) has brought significant advantages. This study delves into peer-reviewed research articles spanning the years 2020 to 2022, focusing on AI-driven methodologies for the analysis and screening of COVID-19 through chest CT scan data. We assess the efficacy of deep learning algorithms in facilitating decision making processes. Our exploration encompasses various facets, including data collection, systematic contributions, emerging techniques, and encountered challenges. However, the comparison of outcomes between 2020 and 2022 proves intricate due to shifts in dataset magnitudes over time. The initiatives aimed at developing AI-powered tools for the detection, localization, and segmentation of COVID-19 cases are primarily centered on educational and training contexts. We deliberate on their merits and constraints, particularly in the context of necessitating cross-population train/test models. Our analysis encompassed a review of 231 research publications, bolstered by a meta-analysis employing search keywords (COVID-19 OR Coronavirus) AND chest CT AND (deep learning OR artificial intelligence OR medical imaging) on both the PubMed Central Repository and Web of Science platforms.